Trial intelligence / Profile preview

Perioperative Systemic Lidocaine for Enhanced Bowel Recovery in Bariatric Surgery

NCT02607488Phase 2Suspended

Sponsor
Mansoura University
Start
Nov 2020
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative ileus (POI), postoperative pain, sponsored by Mansoura University. Started Nov 2020; status: suspended.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative ileus (POI)postoperative pain

Beyond the preview

Go deeper on NCT02607488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02607488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call